source
- Sanofi reports shortages of Myozyme and Nexviazyme for Pompe disease after FDA manufacturing warningSanofi has warned that supplies of two medicines used to treat Pompe disease are running low. The company notified patient groups and physicians in the United States and Europe that the shortage af…
- Novo Nordisk CFO sees oral Wegovy rollout boosting outlook and remains upbeat on CagriSemaNovo Nordisk's chief financial officer, Karsten Munk Knudsen, discussed the company's second‑quarter earnings and the progress of the oral Wegovy pill during a recent interview. He highlighted that…